Evidence map›Paper›PMID 26395965›Full record

ArticleCardiovascular research2015

Inhibition of NAADP signalling on reperfusion protects the heart by preventing lethal calcium oscillations via two-pore channel 1 and opening of the mitochondrial permeability transition pore.

Sean M Davidson, Kirsty Foote, Suma Kunuthur, Raj Gosain, Noah Tan, Richard Tyser, Yong Juan Zhao, Richard Graeff, A Ganesan, Michael R Duchen and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Cardiovascular research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it, 50 citations in OpenAlex.

  1. The protein interaction networks of mucolipins and two-pore channels.Biochimica et biophysica acta. Molecular cell research · 2019
    Pooled it
  2. Article
  3. Allosteric switching of CaThe EMBO journal · 2026
    Article
  4. Article
  5. Review
  6. CaBiomedicines · 2025
    Review
  7. Store-Operated CaJournal of clinical medicine · 2023
    Review
  8. Article
  9. Review
  10. Function and Role of Histamine HPharmaceuticals (Basel, Switzerland) · 2023
    Review
  11. Article
  12. NAADP-Mediated CaHandbook of experimental pharmacology · 2023
    Article
  13. Article
  14. Two-pore channels: going with the flows.Biochemical Society transactions · 2022
    Article
  15. Review
  16. Article
  17. Nicotinic Acid Adenine Dinucleotide Phosphate Induces Intracellular CaFrontiers in cell and developmental biology · 2022
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 3 countries.

Sean M DavidsonThe Hatter Cardiovascular Institute, University College London, 67 Chenies Mews, WC1E 6HX London, UK s.davidson@ucl.ac.uk.
Kirsty FooteThe Hatter Cardiovascular Institute, University College London, 67 Chenies Mews, WC1E 6HX London, UK.
Suma KunuthurThe Hatter Cardiovascular Institute, University College London, 67 Chenies Mews, WC1E 6HX London, UK.
Raj GosainSchool of Chemistry, University of Southampton, Highfield, Southampton, UK.
Noah TanThe Hatter Cardiovascular Institute, University College London, 67 Chenies Mews, WC1E 6HX London, UK.
Richard TyserThe Hatter Cardiovascular Institute, University College London, 67 Chenies Mews, WC1E 6HX London, UK.
Yong Juan ZhaoDepartment of Physiology, Li Ka Shing School of Medicine, The University of Hong Kong, Hong Kong, China.
Richard GraeffDepartment of Physiology, Li Ka Shing School of Medicine, The University of Hong Kong, Hong Kong, China.
A GanesanSchool of Pharmacy, University of East Anglia, Norwich, UK.
Michael R DuchenDepartment of Cell and Developmental Biology, University College London, London, UK.
Sandip PatelDepartment of Cell and Developmental Biology, University College London, London, UK.
Derek M YellonThe Hatter Cardiovascular Institute, University College London, 67 Chenies Mews, WC1E 6HX London, UK.
University College London · GBChinese University of Hong Kong · CNUniversity of East Anglia · GBUniversity of Southampton · GB

Funding

Biotechnology and Biological Sciences Research Council BB/G013721/1Biotechnology and Biological Sciences Research Council BB/K000942/1British Heart Foundation PG/09/106/28142British Heart Foundation PG-10-005British Heart Foundation RG/08/015/26411Medical Research Council EAA/17568Medical Research Council MR/K000608/1
6 · The paper itself

Abstract

aimsIn the heart, a period of ischaemia followed by reperfusion evokes powerful cytosolic Ca(2+) oscillations that can cause lethal cell injury. These signals represent attractive cardioprotective targets, but the underlying mechanisms of genesis are ill-defined. Here, we investigated the role of the second messenger nicotinic acid adenine dinucleotide phosphate (NAADP), which is known in several cell types to induce Ca(2+) oscillations that initiate from acidic stores such as lysosomes, likely via two-pore channels (TPCs, TPC1 and 2). METHODS AND

resultsAn NAADP antagonist called Ned-K was developed by rational design based on a previously existing scaffold. Ned-K suppressed Ca(2+) oscillations and dramatically protected cardiomyocytes from cell death in vitro after ischaemia and reoxygenation, preventing opening of the mitochondrial permeability transition pore. Ned-K profoundly decreased infarct size in mice in vivo. Transgenic mice lacking the endo-lysosomal TPC1 were also protected from injury.

conclusionNAADP signalling plays a major role in reperfusion-induced cell death and represents a potent pathway for protection against reperfusion injury.

Indexed as

AnimalsCalcium ChannelsCalcium SignalingCarbolinesCytoprotectionDisease Models, AnimalDose-Response Relationship, DrugMaleMice, Inbred C57BLMice, KnockoutMitochondria, HeartMitochondrial Membrane Transport ProteinsMitochondrial Permeability Transition PoreMitochondrial SwellingMyocardial InfarctionMyocardial Reperfusion Injury1-(3-((4-(2-fluorophenyl)piperazin-1-yl)methyl)-4-methoxyphenyl)-2,3,4,9-tetrahydro-1H-pyrido(3,4-b)indole-3-carboxylic acidCalcium ChannelsCarbolinesMitochondrial Membrane Transport ProteinsMitochondrial Permeability Transition PoreNAADPNADPNed-K compoundPiperazinesTPCN1 protein, mouseTwo-Pore ChannelsCalciumIschaemiaLysosomesNAADPReperfusion

Identifiers

PMID26395965
PMCPMC4648198
OpenAlexW2175918849

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.